Benefits of immunotherapy combination persist for more than six years in advanced melanoma
2021-05-27
(Press-News.org) Higher percentage of patients treated with nivolumab and ipilimumab in clinical trial reach the six-and-a-half-year survival mark than those treated with either drug alone.
BOSTON - In the longest follow-up results from a clinical trial of combination immunotherapy for metastatic melanoma, investigators report that nearly half the patients who received the drugs nivolumab and ipilimumab were alive a median of six and a half years after treatment. The results, stemming from the CheckMate 067 clinical trial, represent a new landmark in survival rates for patients with melanoma treated with immune checkpoint inhibitor drugs.
F. Stephen Hodi, MD, the director of the Melanoma Center and the Center for Immuno-Oncology at Dana-Farber Cancer Institute is co-senior author of the study. Findings will be presented at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting, being held virtually June 4-8.
The clinical trial compared nivolumab and ipilimumab, alone and in combination, in patients with previously untreated stage III or IV melanoma that could not be removed surgically. Both drugs target proteins on T cells known as immune checkpoints, which some cancer cells exploit to spare themselves from an attack by the T cells. By interfering with these proteins, the drugs essentially release the brakes on such an attack. Nivolumab targets the PD-1 checkpoint protein, ipilimumab targets the CTLA-4 checkpoint protein.
In the trial, patients were randomly assigned to receive nivolumab and ipilimumab in combination, nivolumab plus a placebo, or ipilimumab alone. Six and a half years after treatment, participants who received the nivolumab-ipilimumab combination were more likely to be alive and to have had no advance of their disease than those who received either drug alone.
At the six-and-a-half-year mark, 49% of participants treated with the combination therapy were alive, compared to 42% of those treated with nivolumab alone, and 23% of those treated with ipilimumab alone. Progression-free survival - the percentage of patients alive and whose cancer hadn't worsened - was 34% for the combination therapy group, 29% for the nivolumab-only group, and 7% for the ipilimumab-only group.
Median survival - the length of time that at least half the patients were still alive - followed the same pattern. For patients treated with nivolumab and ipilimumab, median survival was 72.1 months, or just over six years. For those treated with just nivolumab, median survival was 36.9 months, and for those treated with just ipilimumab, it was 19.9 months.
"This is the longest follow up for a phase III advanced melanoma clinical trial including nivolumab plus ipilimumab," said Hodi. "It confirms a continued durable benefit for the combination."
INFORMATION:
The clinical trial was supported by Bristol Myers Squibb.
CheckMate 067: 6.5-year outcomes in patients (pts) with advanced melanoma (abstract 9506) will be presented virtually during the Melanoma/Skin Cancers Oral Abstract Session on Sunday, June 6, 2021, 8:00am-11:00am.
For all ASCO-related media inquiries, call or email Victoria Warren, 617-939-5531, Victoria_Warren@dfci.harvard.edu. Follow the meeting live on Twitter using the hashtag #ASCO21 and follow Dana-Farber on Twitter at @DanaFarberNews.
About Dana-Farber Cancer Institute
Dana-Farber Cancer Institute is one of the world's leading centers of cancer research and care. Dana-Farber's mission is to reduce the burden of cancer through scientific inquiry, clinical care, education, community engagement, and advocacy. The Institute provides the latest treatments in cancer for adults through Dana-Farber/Brigham and Women's Cancer Center and for children through Dana-Farber/Boston Children's Cancer and Blood Disorders Center.
Dana-Farber is the only hospital nationwide with a top 6 U.S. News & World Report Best Cancer Hospital ranking in both adult and pediatric care.
As a global leader in oncology, Dana-Farber is dedicated to a unique and equal balance between cancer research and care, translating the results of discovery into new treatments for patients locally and around the world, offering more than 1,100 therapeutic and non-therapeutic clinical trials.
ELSE PRESS RELEASES FROM THIS DATE:
2021-05-27
URBANA, Ill. - As the owner of a human body, you're carrying trillions of microbes with you everywhere you go. These microscopic organisms aren't just hitching a ride; many of them perform essential chemical reactions that regulate everything from our digestion to our immune system to our moods.
One important set of reactions relates to fat absorption via bile acids. Our livers make these acids to help digest fats and fat-soluble vitamins as they travel through the small intestine. Near the end of the small intestine, microbes convert the acids into new forms, which can either be beneficial or ...
2021-05-27
Over the past 20 years, first-principles simulations have become powerful, widely used tools in many, diverse fields of science and engineering. From nanotechnology to planetary science, from metallurgy to quantum materials, they have accelerated the identification, characterization, and optimization of materials enormously. They have led to astonishing predictions--from ultrafast thermal transport to electron-phonon mediated superconductivity in hydrides to the emergence of flat bands in twisted-bilayer graphene-- that have gone on to inspire remarkable experiments.
The current push to complement ...
2021-05-27
WASHINGTON -- Researchers have developed a new technique that allows microscopic fluorescence imaging at four times the depth limit imposed by light diffusion. Fluorescence microscopy is often used to image molecular and cellular details of the brain in animal models of various diseases but, until now, has been limited to small volumes and highly invasive procedures due to intense light scattering by the skin and skull.
"Visualization of biological dynamics in an unperturbed environment, deep in a living organism, is essential for understanding the complex biology of living organisms ...
2021-05-27
Five years on from the first discovery of gravitational waves, an international team of scientists, including from the ARC Centre of Excellence for Gravitational Wave Discovery (OzGrav), are continuing the hunt for new discoveries and insights into the Universe. Using the super-sensitive, kilometre-sized LIGO detectors in the United States, and the Virgo detector in Europe, the team have witnessed the explosive collisions of black holes and neutron stars. Recent studies, however, have been looking for something quite different: the elusive signal from a solitary, rapidly-spinning neutron star.
Take a star similar in size to the Sun, squash it down to a ball about ...
2021-05-27
The hunt for the never before heard "hum" of gravitational waves caused by mysterious neutron stars has just got a lot easier, thanks to an international team of researchers.
Gravitational waves have only been detected from black holes and neutron stars colliding, major cosmic events that cause huge bursts that ripple through space and time.
The research team, involving scientists from the LIGO Scientific Collaboration (LSC), Virgo Collaboration and the Centre for Gravitational Astrophysics (CGA) at The Australian National University (ANU), are now turning their eagle eye to spinning neutron stars to detect the waves.
Unlike the massive bursts caused by black holes or neutron stars colliding, the researchers ...
2021-05-27
AMHERST, Mass. - New research by University of Massachusetts Amherst astronomer Daniel Wang reveals, with unprecedented clarity, details of violent phenomena in the center of our galaxy. The images, published recently in Monthly Notices of the Royal Astronomical Society, document an X-ray thread, G0.17-0.41, which hints at a previously unknown interstellar mechanism that may govern the energy flow and potentially the evolution of the Milky Way.
"The galaxy is like an ecosystem," says Wang, a professor in UMass Amherst's astronomy department, whose findings are a result of more than two decades of research. "We know the centers of galaxies are where the action is and play an enormous role in their evolution." And yet, whatever has ...
2021-05-27
Individuals with genetic high cholesterol, heart disease or both, who were infected with COVID-19 had more heart attacks according to new research by the FH Foundation. While previous studies have speculated about poorer outcomes if a person with genetic high cholesterol - called familial hypercholesterolemia (FH) contracts COVID-19, this study from the FH Foundation's national healthcare database is the first to demonstrate higher heart attack rates in the real world. Published online in the American Journal of Preventive Cardiology, the study also importantly confirms that COVID-19 increases heart attack rates in individuals with established atherosclerotic cardiovascular disease (ASCVD).
The FH Foundation performed an analysis of 55,412,462 individuals, separating groups into six ...
2021-05-27
Leesburg, VA, May 27, 2021--According to an open-access Editor's Choice article in ARRS' American Journal of Roentgenology (AJR), accurate prenatal diagnosis of severe placental accreta spectrum (PAS) disorder by imaging could help guide maternal counseling and selection between hysterectomy and uterine-preserving surgery.
"The findings suggest strong performance of placental bulge in diagnosing severe PAS on both ultrasound and MRI, with potentially relatively stronger performance on MRI," wrote corresponding author Manjiri Dighe from the department of radiology at the University of Washington School of Medicine. "Nonetheless, interobserver agreement remains suboptimal on both modalities."
On ultrasound and MRI alike, the placental bulge sign represents ...
2021-05-27
A small Japanese fishing community devastated by the Great East Japan Earthquake and Tsunami of 2011 managed to recover from the disaster through cooperative community activity despite the propensity for individualist-competitive behavior within fisheries - cooperative activity that continued many years later.
A social scientist who spent years interviewing fishers in the fishing hamlet of Isohama has discovered a long-standing continuum of competitive and collective endeavor amongst fishers, with potential ramifications for how government policy can better promote resilience in the wake of natural disasters and other calamities.
The findings appear in the journal of Disaster ...
2021-05-27
Using the circular vibration of surface acoustic waves, a collaborative research group have successfully controlled the magnetization of a ferromagnetic thin film.
Their research was published in the journal Nature Communications on May 10, 2021.
Essentially, acoustic waves are waves of atomic vibrations in a substance. When the waves propagate across the surface of a material, the vibration becomes circular. This circular motion, known as angular momentum, can help measure rotational motion.
Surface acoustic waves are utilized in bandpass filters in cell phones. The bandpass allows certain frequencies ...
LAST 30 PRESS RELEASES:
[Press-News.org] Benefits of immunotherapy combination persist for more than six years in advanced melanoma
